D K Boehm, A W Maksymiuk. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » Antineoplastic Agents, Phytogenic/adverse effectsAntineoplastic Agents, Phytogenic/therapeutic useBreast Neoplasms/drug therapyCimetidine/administration & dosageCimetidine/therapeutic useDexamethasone/administration & dosageDexamethasone/adverse effectsDexamethasone/therapeutic useDrug Hypersensitivity/prevention & controlFemaleGlucocorticoids/administration & dosageGlucocorticoids/adverse effectsGlucocorticoids/therapeutic useHistamine H2 Antagonists/administration & dosageHistamine H2 Antagonists/therapeutic useHumansInfusions, IntravenousOvarian Neoplasms/drug therapyPaclitaxel/administration & dosagePaclitaxel/adverse effectsPaclitaxel/therapeutic usePremedicationRanitidine/administration & dosageRanitidine/therapeutic use
Substances： See more » Antineoplastic Agents, PhytogenicGlucocorticoidsHistamine H2 AntagonistsDexamethasoneCimetidineRanitidinePaclitaxel
Year: 1996 PMID： 8618242 DOI： 10.1093/jnci/88.7.463
Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506